Clinical trial
Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially…
NCT00174577 · Rhode Island Hospital, Other · Unknown status
Key facts
| NCT number | NCT00174577 |
|---|---|
| Title | Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant |
| Official title | Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to an Adequate Trial of Antidepressant |
| Lead sponsor | Rhode Island Hospital, Other |
| Collaborators | Janssen Pharmaceutica N.V., Belgium Industry Emory University |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 84 |
| Start date | Feb 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: